SCHEMBL20176953

SCHEMBL20176953

CN(CC1CCC(Br)CC1)C(=O)OC(C)(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 1/20 0.34
HTR2C P28335 4/20 0.34
SLC6A4 P31645 4/20 0.34
HTR2A P28223 1/20 0.33
FPR3 P25089 1/20 0.33
FPR2 P25090 1/20 0.33
NR1H2 P55055 1/20 0.33
LIMK2 P53671 1/20 0.32
KMT2A Q03164 1/20 0.32
SPR P35270 1/20 0.32
PTGIR P43119 1/20 0.32
ASGR1 P07306 1/20 0.31
NFKB1 P19838 1/20 0.31
NFKB2 Q00653 1/20 0.31
RELA Q04206 1/20 0.31
ALOX5 P09917 1/20 0.31
HDAC1 Q13547 1/20 0.30
HDAC2 Q92769 1/20 0.30
HDAC6 Q9UBN7 1/20 0.30
CTSS P25774 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15017085 0.92 CNR2 (0.38) CNR2HTR2CSLC6A4HTR2AFPR3
SCHEMBL25568400 0.85 NR1H2 (0.36) CNR2HTR2CSLC6A4HTR2AFPR3
SCHEMBL6019334 0.85 NR1H2 (0.43) CNR2HTR2CSLC6A4HTR2AFPR3
SCHEMBL6019337 0.85 NR1H2 (0.43) CNR2HTR2CSLC6A4HTR2AFPR3
SCHEMBL25568402 0.85 NR1H2 (0.36) CNR2HTR2CSLC6A4HTR2AFPR3
SCHEMBL24438464 0.85 ALOX5 (0.39) CNR2HTR2CSLC6A4HTR2ALIMK2
SCHEMBL25568401 0.84 CNR2 (0.34) CNR2HTR2CSLC6A4HTR2AFPR3
SCHEMBL25568399 0.84 CNR2 (0.34) CNR2HTR2CSLC6A4HTR2AFPR3
SCHEMBL30157292 0.84 PLG (0.38) CNR2HTR2CSLC6A4HTR2AFPR3
SCHEMBL8911411 0.83 HTR2C (0.42) HTR2CSLC6A4HTR2AALOX5CTSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018093569-A1 SUBSTITUTED BICYCLE HETEROCYCLIC DERIVATIVES USEFUL AS ROMK CHANNEL INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2018-05-24 WO disclosed